Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

For what it’s worth

jbuffett62

Jul 19, 2023 10:06AM

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: For what it’s worth

in response to

For what it’s worth

jbuffett62

posted on Jul 19, 2023 10:40AM

This appears to be a stand-alone for ZEN 3694. ???

https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCI-2022-09605&r=1

https://classic.clinicaltrials.gov/ct2/show/NCT05607108

Koo

3 Recommendations

Re: For what it’s worth

tada

Jul 19, 2023 05:11PM

Re: For what it’s worth

tada

Jul 19, 2023 05:13PM

Re: For what it’s worth

KOO-KOO2

Jul 20, 2023 06:52AM

Re: For what it’s worth

jbuffett62

Jul 20, 2023 08:04AM

Re: For what it’s worth

Buckeyes

Jul 20, 2023 08:18AM

Re: For what it’s worth

jbuffett62

Jul 20, 2023 08:35AM

Reply New Message

Back To Forum List View

Please to post a reply